Ruxolitinib Inhibits IFNγ-stimulated Sjögren's Salivary Gland MSC HLA-DR Expression and Chemokine-Dependent T-cell Migration.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2022
published in
- Rheumatology (Oxford, England) Journal